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Abstract. The synthesis of two of the Escherichia coli glycogen biosynthetic enzymes, ADPglu- 
cose pyrophosphorylase (glgC) and glycogen synthase (gIgA) was activated by the addition of 
5 mM cyclic AMP (cAMP) to maxicells; synthesis of glycogen branching enzyme (glgB) was 
unaffected./3-Galactosidase activity expressed from a gene fusion, 4~(glgC-lacZ), was approxi- 
mately five-fold higher in a cya ÷ versus an isogenic cya strain of E. coli. Addition of cAMP 
restored /3-galactosidase in the cya- strain. The expression of ~b(glgC'-'lacZ) encoded /3- 
galactosidase activity in a series of spoT mutants exhibited an apparent exponential relationship 
to intracellular guanosine 5'-diphosphate 3'-diphosphate (ppGpp) levels. These results provide 
evidence for the control of glycogen biosynthesis in vivo by cAMP and ppGpp at the level of 
gene expression, and identify a region of DNA required for the control. The qb(glgC'-'lacZ) 
encoded/3-galactosidase activity was also elevated three- to five-fold in strain AC70RI, which 
contains a transacting mutation (glgQ) that affects the levels of the glycogen biosynthetic 
enzymes and glgC transcripts. 
The rate of glycogen biosynthesis in Escherichia coli 
is inversely related to nutrient availability and to the 
growth rate [reviewed in 9]. Thus, a complex of 
various controls are most likely required to coordi- 
nate the synthesis of glycogen to the physiological 
state of the culture. At least two levels of control 
are involved. The first step of the biosynthetic path- 
way is catalyzed by ADP glucose pyrophosphory- 
lase, and a considerable body of information has 
shown that this step is controlled allosterically in 
response to intracellular metabolite levels [9]. In 
addition, the observed variations in the intracellular 
levels of the three biosynthetic enzymes suggest reg- 
ulation at the level ofgene expression [9-12]. Recent 
studies with coupled transcription-translation 
assays in S-30 extracts indicated that the expression 
ofglgC (ADP glucose pyrophosphorylase) and glgA 
(glycogen synthase) is under positive control of 
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cAMP and ppGpp [15]. The expression of the glgB 
gene (glycogen branching enzyme) was unaffected 
by either compound and was proposed to reside 
in an operon separate from glgC and glgA. In the 
presence of cAMP receptor protein (CRP), cAMP 
was also effective in stimulating the expression of 
glgC and glgA in a compositionally defined assay, 
which measures the formation of the first dipeptide 
of specific gene products [ 15, 20]. Although the ef- 
fects of ppGpp were reproducibly observed with 
S-30 extracts, no significant effects were observed 
under the conditions of the dipeptide synthesis 
assay, and it was suggested that one or more addi- 
tional factors may mediate the effect [15, 20]. 
The present studies were designed to measure 
the effects of the catabolite repression system and 
the stringent response system on the expression of 
the glycogen biosynthetic genes in vivo and to delin- 
eate the region of DNA in the glg gene cluster that 
contains the cis-acting control sites for regulation. 
The effects of cAMP on glgC, glgA, and glgB were 
determined in a maxicell expression assay system. 
The 5'-flanking region of glgC was subcloned into 
pMLB1034 and /3-galactosidase activity expressed 
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from the resulting glgC'-lacZ gene fusion was as- 
sessed in mutant strains of E. coli. The results of 
these studies support observations made with the 
S-30 assay and indicate that both cAMP and ppGpp 
regulate expression of the glgC gene. Evidence is 
presented to suggest that the previously identified 
glgQ mutation does not affect catabolite repression 
or stringent response, and therefore identifies a third 
system that regulates glg gene expression. 
Materials and Methods 
Chemicals and reagents. The [35S]methionine (1.4 mCi//xmol) was 
purchased from Amersham Corp. (Arlington Heights, Illinois). 
The cAMP, IPTG (isopropyl-/3-o-thiogalactopyranoside), antibi- 
otics, and ONPG (o-nitrophenyl-/3-o-galactopyranoside) were 
from Sigma Chemical Co., (St. Louis, Missouri). Enzymes for 
DNA manipulation and analysis were from sources previously 
indicated [13, 14]. Water was deionized and purified through a 
MilliQ system (Millipore Corp., Bedford, Massachusetts) prior 
to use. 
Bacterial strains and media. The strains used in these studies 
included wild type E. coil B and E. coli B AC70R1 (glgQ) [9], 
CF747 (pyrG ÷ recA1 thi-1 pyrE60 argE3 his-4 proA2 thr-1 leuB6 
mtl-l xyl-5 ara-14 galK2 lacY1 rpsL31 supE44 cdd gyrA(Nal) 
relAlh-spoT+), CF954-956 (recA56 srl-3OO::TnlO pyrE + his + 
pyrG + thi-1 argE3 proA2 thr-1 leuB6 Mtl-I xyl-5 ara-14 galK2 
lacY1 rpsL31 supE44 cdd gyrA(Nal) relAlh-spoT202-204) [18], 
ML2 (met gal, hsdkR supE supF Km Acya) [3], and ED8654 (met 
gal hsdkR supE supF) [3], MBM7060 (F- araC am araD (argF- 
lac)U169 trp am malB am rpsL relA thi supF (hp 1048)) [19], 
HB101 (FphsdS20(rB mB )recA13ara-14proA21acY1 gaIK2 
rpsL20(Sm r) xyl-5 mtl-I supE44h ) [6], MCL22 (trkA405 trkDl 
thi A( kdp-phr )214 rha 8( gal-uvrB ) A( srl-rec A )306 rps L31) [5]. The 
preparation of Kornberg medium [ 15] and MOPS minimal medium 
[18] was previously described. The M9 minimal medium con- 
tained 0.6% Na2HPO 4, 0.3% KH2PO4, 0.5% NaCI, and 0.15% 
NHaCI. M9-supplemented medium is M9 minimal medium plus 1 
mM MgSo 4, 0.1 mM CaCI 2, 2 /zg biotin ml, 1 ktg thiamine ml, 
0.4% casamino acids, and 0.5% glucose. M9 sulfate-free medium 
was M9-supplemented medium with the substitution of MgC12 for 
MgSO 4 and without casamino acids. 
Plasmids. The plasmid pMLB1034 was previously described [19]. 
Plasmid pOP12 contains the E. coli glycogen biosynthetic genes 
cloned into pBR322 [8]. Plasmid pOP189 is an EcoRl-generated 
derivative of pOPI2 that lacks the glgC and glgA genes [8]. The 
plasmid pCZ3 was constructed by ligating a 0.7 KbHincll-BamHl 
restriction fragment from pOP12 into the SmaI-BamHl site of 
pMLB1034, and transforming HB101 to ampicillin resistance. 
The plasmid pCZ3 was characterized by restriction endonuclease 
mapping and contained an out-of-frame fusion of the glgC and 
lacZ genes. A previously described in vivo method for isolating 
in-frame mutations of plasmid-encoded lacZ gene fusions [19] 
was used to obtain several such plasmids. These were charac- 
terized by restriction mapping. The plasmid chosen for study, 
pCZ3-3, resulted from an 8-bp deletion event which removed the 
single BamHI site in pCZ3. Codon 64 of glgC is fused to codon 
9 oflacZ in pCZ3-3 (T. Romeo and J. Preiss, unpublished nucleo- 
tide sequence data). The procedures utilized in plasmid construc- 
tion were previously described [15, 16]. 
Maxicell analysis. The maxicell procedure was used for identifica- 
tion of plasmid-encoded proteins [17], with minor modifications 
suggested by Dr. M. C. Lorence (University of Texas Health 
Science Center at Dallas). Exponential cultures from MCL22, 
which had been transformed with the plasmids of interest, were 
grown to an absorbance of 0.60 at 450 nm in M9-supplemented 
medium containing tetracycline (20/~g/ml), irradiated with short- 
wave UV light, and mixed with an equal volume of M9-supple- 
mented medium. Cultures were incubated at 37°C for 3 h and 
treated with cycloserine (200/~g/ml). Cultures were incubated an 
additional 3 h and treated again with cycloserine. After overnight 
incubation, the cultures were treated a third time with cycloser- 
ine, washed and resuspended in sulfate-free M9 medium, and 
incubated for 1 h. The cultures were then split into two 2.5-ml 
portions, and cAMP (5 mM) was added to one of the portions. 
The cultures were incubated for 10 min and were labeled with 
[35S]methionine (5/~Ci/ml) for 1 h. Cells were washed with M9 
minimal medium, suspended in lysis buffer (0.125 M Tris, pH 6.8, 
4% SDS, 20% glycerol, 10% 2-mercaptoethanol), and heated for 
2 min at 100°C. Equal volumes of cell proteins (20/~L from 100 
/zL of cell extract) were analyzed in 10% SDS polyacrylamide 
slab gels with the buffer system of Laemmli [4]. The gels were 
stained with Coomassie blue, and labeled proteins were visualized 
by fluorography, as described [15]. 
fl-galactosidase assays. Assays were carried out according to 
Miller [7] with minor modification. Bacterial cultures were grown 
in either MOPS minimal medium or Kornberg medium containing 
0.2% glucose and 100 p.g/ml ampicillin at 37°C with gyratory 
shaking at 200 rpm. For enzyme assays, 0.125 ml of culture 
was added to 0.5 ml of 0.1 M sodium phosphate buffer, pH 
7.0,containing 0.2 M KCI, 0.002 M MgSO 4, 0.1 M 2-mercapto- 
ethanol, and 100/~g/ml chloramphenicol. This was followed by 
addition of 0.25 ml of 300/.Lg/ml sodium deoxycholate and one 
drop of toluene. The reactions were shaken at 37°C for 30 min, 
cooled to room temperature, and 0.25 ml of 13.3 mM o-nitrophe- 
nyl /3-D-galactopyranoside (ONPG) or water (for no substrate 
blanks) was added. The enzymatic reactions were allowed to 
proceed for 10 min at 22°C and were stopped by the addition of 
I N K2CO 3. The reactions were subjected to centrifugation to 
eliminate turbidity, and absorbance of each reaction was deter- 
mined at 420 nm, relative to an identical blank reaction that lacked 
ONPG. In order to correct for differences in cell mass of the 
cultures during these experiments, the enzyme activity (A420) was 
normalized relative to cell mass (A6o~). In order to calculate/3- 
galactosidase expressed from 4~(glgC'-lacZ), the uninduced ex- 
pression from the chromosomal copy of lacZ was estimated by 
measuring /3-galactosidase activity from strains containing 
pMLVI034 and was subtracted from the activity from pCZ3-3- 
containing strains. Although the large number of samples required 
for these studies prohibited the determination of more than a 
single experimental value for each time point, each of the growth 
curve experiments has been conducted at least twice, with similar 
results. 
R e s u l t s  
Effects of cAMP on the expression of gig genes in 
maxicells. The maxicell technique was used in order 
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Fig. 1, Expression of gig genes in maxicells. Plasmid-encoded 
proteins synthesized by E. coli MCL22 were analyzed by the 
maxicell procedure, as described in Materials and Methods. Fluo- 
rographic analysis of [35S]methionine-labeled proteins from cells 
containing pBR322, lanes A and D; pOPl2, lanes B and E; and 
pOPI89, lanes C and F, are shown, cAMP (5 raM) was added to 
cultures shown in lanes D, E, and F. The bands corresponding to 
the labeled products of glgB, glgC, and glgA were identified 
by comparison with purified standards of glycogen branching 
enzyme, 85 kDa; ADP glucose pyrophosphorylase, 48 kDa; and 
glycogen synthase, 52 kDa, respectively. The other labeled prod- 
ucts of asd, tet, and bla were identified by comparison of their 
mobilities with those of the above marker proteins and the inabili- 
ties of bovine serum albumin, 67 kDa; ovalbumin, 45 kDa; and 
carbonic anhydrase, 29 kDa. 
to examine the effect of exogenous cAMP on the in 
viva expression of the glycogen biosynthetic genes. 
Figure 1 shows that several plasmid-encoded pro- 
teins were synthesized in strain MCL22[pOP12] but 
not in MCL22[pBR322]. The overall pattern was 
similar to that of the proteins expressed in vitro from 
pOP12 [16]. The three largest labeled proteins were 
identical in electrophoretic mobility with purified 
standards of ADPglucose pyrophosphorylase (49 
kDa), glycogen synthase (52 kDa), and glycogen 
branching enzyme (84 kDa). Further information on 
the identity of these three proteins was obtained 
with strain MCL22[pOPI89]. Plasmic pOP189 is a 
deletion derivative of pOPl2 and lacks part of the 
glgC gene and all of the glgA. Therefore, this plas- 
mid does not encode ADP glucose pyrophosphory- 
lase and glycogen synthase activities [8]. The in viva 
labeled proteins from MCL22[pOP189] no longer in- 
clude those presumed to be ADP glucose pyrophos- 
phorylase and glycogen synthase [Fig. 1, lanes C 
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Fig. 2. Construction of an in-frame glgC'-lacZ gene fusion. 
and F). The addition of 5 mM cAMP to maxicells 
resulted in a significant increase in the incorporation 
of [35S] into ADP glucose pyrophosphorylase and 
glycogen synthase [Fig. 1, lane El. The synthesis of  
glycogen branching enzyme showed little or no ef- 
fect upon addition of cAMP. This suggested that the 
effect of cAMP was at the level of glgC and glgA 
gene expression, and was not owing to nonspecific 
effects such as alteration of the intracellular methio- 
nine pool. 
Expression of  a lacZ gene fusion under the glgC 
regulatory controls. In order to simplify the examina- 
tion of the effects of ppGpp and other trans-acting 
regulatory factors on in viva expression of the glyco- 
gen genes, we constructed a plasmid-encoded lacZ 
gene fusion [Fig. 2]. The plasmid pCZ3-3 contains 
0.5 kb of DNA flanking the 5' end of glgC and 64 
codons of the glgC gene fused to codon 9 of lacZ 
(unpublished nucleotide sequence analysis, T. Ro- 
meo and J. Preiss). Transformation of appropriate 
strains with pCZ3-3 allowed the use of/3-galactosi- 
dase activity as an assay for the effects of  trans- 
acting mutations on the expression ofglgC. A lacZ- 
strain of E. coli, MBM7060, was transformed with 
134 CURRENT MICROBIOLOGY Vol. 21 (1990) 
Table 1. /3-Galactosidase levels in MBM7060 a 
pCZ3-3 p M L B  1034 
T I M E  (h) - IPTG + IPTG IPTG + ITPG 
2.0 0.023 0.057 0.000 0.000 
4.8 0.085 0.090 0.007 0.018 
18.0 0.230 0.217 0.006 0.010 
Values are expressed  as f l-galactosidase activity/cell  mas s  
(A420/A600). 
pMLB 1034 and pCZ3-3, and/3-galactosidase activity 
was measured in both transformants. Table 1 shows 
that (i) no /3-galactosidase activity was expressed 
from pMLB1034, which lacks the glgC DNA; (ii) 
the expression of/3-galactosidase from pCZ3-3 is 
not affected by IPTG, the gratuitous inducer of the 
native lacZ gene; and (iii) pCZ3-3-encoded activity 
is elevated in stationary phase, as would be expected 
if the expression of/3-galactosidase is under glgC 
regulatory control. 
In order to examine the effect of cAMP on glgC 
expression, isogenic strains ED8654 (cya +) and 
ML2 (Acya) were transformed with pCZ3-3,and 
pCZ3-3-encoded/3-galactosidase activity was deter- 
mined throughout the growth curve. Figure 3 shows 
that the growth rate of these strains was essentially 
identical under the conditions shown; however, the 
synthesis of plasmid-encoded /3-galactosidase was 
approximately fivefold higher in ED8654 than in 
ML2 throughout the growth curve. The addition of 
5mM cAMP to the cultures resulted in a stimulation 
of the synthesis of plasmid-encoded/3-galactosidase 
activity in ML2 almost to the level observed in 
ED8654 and resulted in an increase of activity of 
approximately 50% in ED8654. The growth rate of 
each strain was decreased to a similar extent in the 
presence of exogenous cAMP. 
The effect of ppGpp on expression of the 
glgC'-lacZ gene was assessed by a series of spoT 
mutants which were impaired to various extents in 
their ability to degrade endogenous ppGpp [18]. The 
elevated intracellular levels of ppGpp in these strains 
result in a decrease in their growth rates. The dou- 
bling times and ppGpp levels for these strains were 
previously shown to exhibit a linear relationship 
[18]. Figure 4 shows the quantitative relationship 
between plasmid-encoded /3-galactosidase activity 
and growth rate of these strains. Maximal activity in 
these strains occurred during the early- to midexpo- 
nential phase, then decreased until the cultures en- 
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Fig. 3. Express ion  of  pC233-encoded fl-galactosidase activity in 
ML2 (2~ cya) and ED 8654 (wt). Cul tures  were grown in Kornberg  
med ium,  and a s says  were conducted  under  condit ions described 
in Materials  and Methods .  Broken lines depict  absorbance  of 
cul tures  of  600 nm; solid lines indicate plasmid-encoded/3-galac-  
tosidase activity corrected for cell mass .  Cul tures  of  ML2 were 
indicated by tr iangles;  ED8654, circles. Solid symbols  indicated 
growth in the presence  of cAMP,  5 mM. 
remained almost constant. This was in contrast to 
the pattern observed for glycogen biosynthetic en- 
zyme levels in many E. coli strains [8-12] and dif- 
fered from the pattern of expression of cb(glgC'- 
lacZ) in other strains [Fig. 3 and Fig. 5]. 
Insets a and b of Fig. 4 compare the doubling 
times for these strains with the plasmid-encoded/3- 
galactosidase activity. Since the intracellular ppGpp 
concentrations vary in a direct linear relationship 
with the doubling times under the growth conditions 
used in these experiments [18], these results estab- 
lish that an exponential relationship exists between 
intracellular ppGpp in these strains and the expres- 
sion of 4~(glgC'-lacZ). Although the copy numbers 
of pCZ3-3 in spoT strains were not measured, the 
effects of these spoT mutations on the copy number 
of a similar pBR322-derived plasmid were minimal 
[18 ] .  
A trans-acting mutation, glgQ, leads to in- 
creases in the levels of the three glycogen biosyn- 
thetic enzymes (approximately tenfold for ADP glu- 
cose pyrophosphorylase and fivefold for glycogen 
synthase [9]) and was recently shown to affect tran- 
scription ofglgC [15]. The strain containing the glgQ 
mutation, E. coli B AC70R1, and wild type E. coli 
B were transformed with plasmid pCZ3-3 or 
pMLB 1034, and the resulting/3-galactosidase activ- 
ity was determined. Table 2 shows that under the 
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Fig. 4. Expression of  pCZ3-3 encoded/~-galactosidase activity in 
spoT strains. Cultures were grown in MOPS medium, and assays 
were conducted as described in the Materials and Methods.  
Growth was plotted as a function of  time on a semilogarithmic 
scale, and plasmid-encoded/3-galactosidase activity has been cor- 
rected for cell mass (Ar00) and plotted on a linear scale. The data 
are shown for CF747 (spoT +) and CV954-956 (spoT202-204) as 
closed circles, open squares,  triangles, and open circles, respec- 
tively. Inset a shows the relationship between doubling time for 
each strain and/3-galactosidase activity plotted on a linear scale; 
inset b shows the same relationship plotted on a semi-logarithmic 
scale. The enzyme activity for each strain was taken from midex- 
ponential,  late exponential ,  or  stationary phase,  and is shown as 
closed circles, open circles, and squares,  respectively.  
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Fig. 5. Express ion of  pCZ3-3-encoded/3-galactosidase activity in 
E. coli B and AC70RI (glgQ). Cultures were grown in Kornberg 
medium, and assays conducted as descr ibed in Materials and 
Methods.  
higher in AC70R1 [Table 2]. Figure 5 compares the 
pattern of 4)(glgC'-'lacZ) expression through the 
growth curves of  these strains. These results suggest 
that the glgQ mutation does not affect the regulatory 
factors responsible for the expression of the native 
lacZ gene, i.e. cAMP, CRP,or ppGpp. However, the 
gtgQ mutation has a significant effect upon the ex- 
pression of 4)(glgC'-'lacZ). 
conditions used for the growth, both E. coli B 
[pBML 1034] and AC70R 1 [pMLB 1034] synthesized 
similar levels of/3-galactosidase. This indicated that 
the glgQ mutation in AC70RI did not alter expres- 
sion of the chromosomal lacZ gene. Additional ex- 
periments to compare the expression of the chromo- 
somal lacZ gene in E. coli B and AC70R1 did not 
alter expression of the chromosomal lacZ gene. Ad- 
ditional experiments to compare the expression of 
the chromosomal lacZ gene in E. coli B and AC70RI 
were carried out in minimal medium in the presence 
or absence of IPTG (6.25 mM) and glucose (0.5%). 
The/3-galactosidase activity from these two strains 
differed by no more than 35% under any condition 
tested (data not shown). In contrast, the expression 
of d)(glgC'-lacZ) of pCZ3-3 was two- to fivefold 
Discussion 
Previous in vitro studies on the expression of genes 
for glycogen biosynthesis indicated that cAMP and 
ppGpp may function to positively alter the level of 
expression ofglgC and glgA [ 15]. Evidence for regu- 
lation in the case of cAMP was particularly strong 
and included the observations that cAMP activated 
the expression of transcription-translation reactions 
and, in the compositionally defined dipeptide syn- 
thesis assay, that the cAMP-CRP complex was ca- 
pable of binding specifically to restriction fragments 
from the region proximal to glgC [15]. However,  
evidence that ppGpp activates the expression of glg 
genes was less definitive. In particular, ppGpp did 
not enhance glgC expression in the dipeptide assay 
[15, 20]. The results of the present study support the 
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Table 2./3-Galactosidase levels in E. coli B and AC70R1 
pMLB 1034 pCZ3-3 A ~ 
TIME (h) E. coli B AC70R1 E. coli B AC70RI E. coli B AC70R1 
2.0 0.265 0.226 0.298 0.303 0.033 0.077 
3.5 O. 172 O. 122 0.251 0.333 0.079 0.211 
21.0 O. 120 O. 140 0.250 0.760 O. 130 0.620 
A indicates the difference between the activities from cells conaining pCZ3-3 and pMLB1034. 
conclusions obtained with the coupled transcription- 
translation assays and indicate that ppGpp activates 
the expression of the glg genes in vivo. It was pre- 
viously noted that ppGpp may require a factor that 
is absent from the dipeptide assay in order to alter 
transcription of the glg genes, or ppGpp may have 
effects on translation [15]. For the latter to be sure, 
the effect of ppGpp on glgC expression must be 
limited to steps of translation subsequent to the for- 
mation of the first dipeptide bond and prior to the 
translation of the 64th codon of glgC, which is the 
extent of glgC DNA in ch(glgC'-lacA). This seems 
an unlikely possibility, and, on the basis of substan- 
tial experimental evidence that ppGpp affects the 
transcription of other gene systems (reviewed in [2]), 
ppGpp probably enhances glgC gene expression at 
the level of transcription. 
The analysis of glgC'-'lacZ expression in spoT 
mutants revealed two unexpected responses. The 
expression of the glycogen biosynthetic enzymes 
is generally maximal in the early stationary phase 
[8-12]. However, fl-galactosidase activity from 
ch(glgC'-'lacZ) exhibited a peak in the midexponen- 
tial phase in spoT strains. This peak of activity is 
likely to reflect fluctuation of the basal ppGPp con- 
centration in these strains, although intracellular lev- 
els of ppGPp in these strains have been measured 
only during the midexponential phase [18]. The sec- 
ond surprising trend in the spoT strains was the 
apparent exponential relationship between ppGpp 
levels and the expression of 6(glgC'-lacZ). This 
relationship appears to be the inverse of that ob- 
served for the activity of the rrnA P1 promoter in 
these strains, which showed an inverse exponential 
relationship to the doubling times and to ppGpp lev- 
els [18]. The precise explanation for these exponen- 
tial responses awaits rigorous biochemical under- 
standing of the mechanism of ppGpp in these 
systems. There is mounting evidence that ppGpp 
may play an important role in general growth rate 
regulation in addition to its well-established involve- 
ment in stringent response [I, 2, and references 
therein]. This is consistent with the observation that 
glycogen biosynthesis varies according to the 
growth rate of the culture [9] and offers a potential 
mechanism for the regulation. 
These studies have further defined the proper- 
ties of the glycogen excess mutant AC70RI, which 
was recently shown to positively affect transcription 
of glgC [16]. It appears that the expression of chro- 
mosome-encoded lacZ is not significantly altered in 
AC70RI. Therefore, glgQ probably does not reside 
in either the catabolite repression or the stringent 
response regulatory systems, which regulate the ex- 
pression of native lacZ [15, 16]. This suggests that 
a third independent regulatory system controls gig 
gene expression. 
On the basis of the limited amount of gig DNA 
that was used in constructing ch(glgC'-'lacZ), cis- 
acting sites required for cAMP, ppGpp, and glgQ 
effects are now known to reside within 0.5 Kb of the 
glgC transitional start site. Previous studies mapped 
5' termini of four discrete transcripts within this 
region [15]. It is now of interest to determine which 
of these transcripts respond to cAMP and/or ppGpp. 
The transcript proximal to the glgC coding region 
was present in high levels in AC70R1 (25-fold higher 
than in E. coli B). However, the site of the glgQ 
mutation and the nature of the factor(s) altered by 
this mutation are not known, presenting an import- 
ant challenge for further investigation. 
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